tiprankstipranks
Trending News
More News >
NOVONIX Ltd Sponsored ADR (NVX)
:NVX
Advertisement

NOVONIX Ltd Sponsored ADR (NVX) AI Stock Analysis

Compare
100 Followers

Top Page

NVX

NOVONIX Ltd Sponsored ADR

(NASDAQ:NVX)

Rating:44Neutral
Price Target:
$1.00
▼(-30.07% Downside)
The overall stock score of 44 reflects significant financial challenges, including operational losses and negative cash flows, which weigh heavily on the company's outlook. Technical analysis provides mixed signals, with no strong momentum to suggest a reversal of the current trend. Valuation concerns due to unprofitability further impact the score. Strategic improvements in financial performance are crucial for enhancing the stock's attractiveness.

NOVONIX Ltd Sponsored ADR (NVX) vs. SPDR S&P 500 ETF (SPY)

NOVONIX Ltd Sponsored ADR Business Overview & Revenue Model

Company DescriptionNOVONIX Ltd Sponsored ADR (NVX) is a leading company in the advanced materials and technology sector, primarily focused on the development and supply of high-performance materials for the lithium-ion battery industry. The company specializes in providing innovative solutions for battery manufacturing, aiming to enhance the performance, longevity, and sustainability of energy storage systems. NOVONIX operates through several divisions, including anode materials, battery technology, and testing services, catering to a global clientele of battery manufacturers, electric vehicle producers, and energy storage companies.
How the Company Makes MoneyNOVONIX Ltd generates revenue through multiple streams primarily associated with the lithium-ion battery supply chain. The company's key revenue sources include the sale of high-purity synthetic graphite anode materials, which are critical components for lithium-ion batteries used in electric vehicles, consumer electronics, and energy storage systems. Additionally, NOVONIX offers battery testing services and technology solutions that provide significant value to manufacturers seeking to optimize battery performance and lifespan. The company's strategic partnerships with industry leaders and ongoing investment in research and development further bolster its revenue potential by fostering innovation and expanding its market reach.

NOVONIX Ltd Sponsored ADR Financial Statement Overview

Summary
NOVONIX Ltd faces significant financial challenges, with negative EBITDA and net income indicating ongoing operational losses. The balance sheet shows moderate leverage, but declining equity and assets indicate financial strain. Negative operating and free cash flows further highlight the need for improved cost management and revenue growth.
Income Statement
22
Negative
NOVONIX Ltd has faced significant challenges in its profitability, with a negative EBITDA and net income indicating ongoing operational losses. The gross profit margin is positive, but the net profit margin is negative due to high operating expenses. Revenue growth is inconsistent, showing a decline from the previous year. These factors suggest financial instability and a need for improved cost management.
Balance Sheet
35
Negative
The balance sheet shows a moderate debt-to-equity ratio, indicating some leverage but not excessive. The equity ratio is relatively strong, suggesting reliance on equity financing. However, declining stockholders' equity and total assets indicate potential financial strain. The company's financial position is relatively stable but needs improvement in asset and equity management.
Cash Flow
30
Negative
The company has negative operating and free cash flow, indicating challenges in generating cash from operations. The free cash flow growth rate is negative, reflecting financial difficulties. The operating cash flow to net income ratio is unfavorable, suggesting issues in converting income into cash. Overall, cash flow management needs significant improvement.
BreakdownDec 2024Dec 2023Dec 2022Jun 2022Jun 2021
Income Statement
Total Revenue5.85M12.13M6.10M5.23M
Gross Profit4.08M9.32M-20.63M4.38M-3.28M
EBITDA-66.61M-38.86M-33.28M-43.26M-12.04M
Net Income-74.82M-46.25M-38.08M-51.86M-18.08M
Balance Sheet
Total Assets226.10M263.34M189.59M302.98M202.86M
Cash, Cash Equivalents and Short-Term Investments42.56M78.63M73.93M142.74M136.66M
Total Debt70.42M68.22M31.34M42.31M20.01M
Total Liabilities88.51M83.74M38.20M51.85M24.68M
Stockholders Equity137.59M183.94M151.39M251.13M178.18M
Cash Flow
Free Cash Flow-70.32M-55.42M-29.65M-113.02M-25.66M
Operating Cash Flow-40.42M-36.23M-12.89M-29.23M-6.09M
Investing Cash Flow-18.17M-12.04M-16.10M-106.80M-19.68M
Financing Cash Flow25.21M44.16M180.69M103.77M

NOVONIX Ltd Sponsored ADR Technical Analysis

Technical Analysis Sentiment
Positive
Last Price1.43
Price Trends
50DMA
1.24
Positive
100DMA
1.20
Positive
200DMA
1.40
Positive
Market Momentum
MACD
<0.01
Negative
RSI
58.00
Neutral
STOCH
52.72
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For NVX, the sentiment is Positive. The current price of 1.43 is above the 20-day moving average (MA) of 1.28, above the 50-day MA of 1.24, and above the 200-day MA of 1.40, indicating a bullish trend. The MACD of <0.01 indicates Negative momentum. The RSI at 58.00 is Neutral, neither overbought nor oversold. The STOCH value of 52.72 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for NVX.

NOVONIX Ltd Sponsored ADR Risk Analysis

NOVONIX Ltd Sponsored ADR disclosed 1 risk factors in its most recent earnings report. NOVONIX Ltd Sponsored ADR reported the most risks in the "Legal & Regulatory" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

NOVONIX Ltd Sponsored ADR Peers Comparison

Overall Rating
UnderperformOutperform
Sector (65)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
65
Neutral
£2.66B12.723.41%3.25%2.43%-21.98%
58
Neutral
$866.54M-22.60%14.82%-19.27%
51
Neutral
$881.71M-33.65%20.84%24.84%
51
Neutral
$2.07B-68.46%60.04%52.49%
44
Neutral
$228.20M-45.13%-14.27%-28.56%
43
Neutral
$95.72M-20.52%48.62%0.23%
43
Neutral
$23.62M-207.48%-16.98%2.43%
* Industrials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
NVX
NOVONIX Ltd Sponsored ADR
1.43
-0.21
-12.80%
FCEL
Fuelcell Energy
4.20
-8.97
-68.11%
MVST
Microvast Holdings
2.71
2.39
746.88%
GWH
ESS Tech
1.65
-6.79
-80.45%
ENVX
Enovix
10.51
0.08
0.77%
SLDP
Solid Power
4.78
3.33
229.66%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Aug 22, 2025